BSHI 2022

22/07/2022

BSHI 2022 | British Society for Histocompatibility and Immunogenetics Conference | 13-14 Sept, 2022, London, UK The opportunity to meet us again is open, as Omixon team will be present at the 32nd Annual British Society for Histocompatibility and Immunogenetics Conference in London, UK. Our experts are looking...

ATC 2022

30/05/2022

ATC 2022 | American Transplant Congress | 4-8 June, 2022, Boston MA The opportunity to meet us again is open, as Omixon team will be present at the Joint Annual Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation in Boston, MA, USA. Our...

EFI 2022

10/05/2022

EFI 2022 | Tolerance, Acceptance and Permissiveness After 2 long years, the opportunity to meet and greet is open again in the event of the 35th EFI Annual Meeting in Amsterdam. Our team is very excited to meet many people from the field again in person. We...

Omixon Launches OmniType, Multiplex For NGS-based HLA Genotyping

30/09/2020

Omixon proudly announces the launch of OmniType, a 11-locus multiplex human leukocyte antigen (HLA) genotyping assay and software product for use on the Illumina® sequencing platforms (such as MiSeq, MiniSeq and iSeq). OmniType offers a revolutionary single working-day workflow that allows processing of samples from gDNA to a ready-to-sequence...

Omixon to Launch OmniType – Join Our Early Access Program!

21/10/2019

Omixon is gearing up to launch a Multiplex HLA typing product for use on Illumina sequencing platforms. This new product line – OmniType – is expected to be a best-in-class product featuring locus multiplexing and short library preparation. The requirements for its development came both from you in the...